Urology · Toledo, OH
NPI
1538145560
Since 2005
Specialty
Urology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2000 Regency Ct, Suite 200
Toledo, OH, 43623
Phone (419) 725-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
3,564 services
Medicare patients, 2024
776
Average age 74
Drug cost, 2024
$518K
4,619 prescriptions
Company payments, 2025
$17.88
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory D Haselhuhn was code 99214 (office e&m - established), 788 times for 578 patients. In total Gregory D Haselhuhn billed 3,564 services in 74 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 788 | 578 | $84.13 | $66K |
| 81003 Clinical Chemistry | Office | 687 | 554 | $2.18 | $1,497 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 264 | 25 | $139.72 | $37K |
| 51798 Ultrasound - Nonspecific | Office | 253 | 180 | $7.43 | $1,880 |
| 99204 Office E&M - New | Office | 138 | 138 | $109.07 | $15K |
| 52000 Cystourethroscopy | Office | 107 | 83 | $152.18 | $16K |
| 99213 Office E&M - Established | Office | 94 | 85 | $61.18 | $5,751 |
| 51741 Test - Miscellaneous | Office | 54 | 43 | $7.53 | $407 |
| 96402 Chemotherapy Administration | Office | 44 | 25 | $25.18 | $1,108 |
| 93000 Electrocardiogram | Office | 42 | 39 | $8.89 | $373 |
| 99222 Hospital E&M - Initial | Facility | 39 | 36 | $96.11 | $3,748 |
| 76872 Ultrasound - Nonspecific | Facility | 28 | 28 | $22.70 | $636 |
| 52287 Cystourethroscopy | Facility | 28 | 18 | $117.61 | $3,293 |
| 55700 Other Organ Systems | Facility | 25 | 25 | $89.44 | $2,236 |
| 76872 Ultrasound - Nonspecific | Office | 23 | 22 | $100.11 | $2,302 |
By year: 2022 $211K for 4,305 services; 2023 $185K for 3,337 services; 2024 $215K for 3,564 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 687 | 554 | $2.18 | $1,497 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory D Haselhuhn prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 683 prescriptions and refills. In total Gregory D Haselhuhn wrote 4,619 Medicare prescriptions that cost $518K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 683 | 1,652 | 199 | $20K |
| Tamsulosin Hcl Generic | 555 | 1,279 | 177 | $10K |
| Finasteride Generic | 519 | 1,478 | 155 | $8,054 |
| Solifenacin Succinate Generic | 369 | 577 | 80 | $20K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 264 | 292 | 116 | $4,640 |
| Cephalexin Generic | 219 | 225 | 175 | $618 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 216 | 385 | 62 | $6,747 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 211 | 239 | 132 | $1,301 |
| Gemtesa Vibegron | 190 | 271 | 46 | $127K |
| Myrbetriq Mirabegron | 147 | 239 | 35 | $103K |
| Potassium Citrate Er Potassium Citrate | 138 | 235 | 29 | $15K |
| Ciprofloxacin Hcl Generic | 126 | 126 | 100 | $385 |
| Cefadroxil Generic | 118 | 118 | 101 | $541 |
| Estradiol Generic | 108 | 185 | 44 | $11K |
| Trospium Chloride Generic | 81 | 123 | 19 | $5,526 |
Brand drugs: - claims; generic drugs: 4,163 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory D Haselhuhn $17.88 ($17.88 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $17.88.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $17.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.